Clinical Governance · E-E-A-T Clinicians

Medical Review Board & Clinical Advisory Panel

Our clinical content is authored, reviewed, and audited by licensed healthcare professionals representing medical oncology, advanced practice infusion nursing, and sterile compounding clinical pharmacy.

Clinical Peer Review: Sarah Jenkins, MSN, RN, CRNI, VA-BC Published: October 2026 Verified Board Member →

1. Clinician Reviewer Profiles

AV
Arthur Vance, MD, FACP
Senior Clinical Oncology & Pharmacology Advisor
Fellow of the American College of Physicians · Johns Hopkins Medicine Alumnus

Dr. Vance brings 22 years of academic and clinical oncology practice, specializing in antineoplastic pharmacology, chemotherapy vesicant extravasation protocols, and biologic infusion hypersensitivities. He served as Director of Outpatient Infusion Services at an NCI-designated Comprehensive Cancer Center and maintains active membership in the American Society of Clinical Oncology (ASCO) and ESMO.

Editorial Scope: Antineoplastic chemotherapy safety, vesicant extravasation antidotes (Dexrazoxane, Hyaluronidase), iron hypersensitivity, and biologic infusion reactions.

SJ
Sarah Jenkins, MSN, RN, CRNI®, VA-BC™
Lead Infusion Nursing Specialist & Review Board Chair
Master of Science in Nursing, University of Pennsylvania · Infusion Nurses Society Member

Sarah Jenkins has over 18 years of clinical experience leading acute hospital vascular access teams and home infusion nursing services. Board certified as a Certified Registered Nurse Infusion (CRNI®) and Vascular Access Board Certified (VA-BC™), she has authored institutional CLABSI reduction bundles and trained over 1,000 nurses on Celsite® port maintenance and non-coring Huber needle access.

Editorial Scope: Vascular access care, PICC line flushing, Celsite port maintenance, bedside checklists, CDC bundles, and caregiver emergency guides.

MF
Marcus Finch, PharmD, BCPPS, BCSCP
Compounding Pharmacy & Drug Compatibility Specialist
Doctor of Pharmacy, UNC Eshelman School of Pharmacy · Board Certified Sterile Compounding Pharmacist

Dr. Finch possesses 16 years of clinical hospital pharmacy cleanroom leadership. As a Board Certified Sterile Compounding Pharmacist (BCSCP), he serves as an independent consultant on USP <797> and USP <800> cleanroom engineering design, closed-system drug-transfer devices (CSTD), and parenteral drug compatibility mechanics.

Editorial Scope: Y-site drug incompatibilities, particulate filtration (USP <788>), DEHP plasticizer toxicology, smart infusion pump DERS libraries, and hazardous drug containment.

2. Editorial Governance Matrix

TABLE 1: MEDICAL REVIEW BOARD OVERSIGHT MATRIX
Clinical Governance · Practice Credentials
Reviewer Name Medical Specialty Board Certifications Clinical Experience Primary Review Scope
Arthur Vance, MD, FACP Medical Oncology & Hematology ABIM Board Certified Oncology; FACP 22 Years Chemotherapy, vesicants, iron infusion, biologics
Sarah Jenkins, MSN, RN, CRNI® Vascular Access & Infusion Nursing CRNI® (Infusion Nurses Society); VA-BC™ 18 Years PICC care, Celsite ports, CLABSI bundles, checklists
Marcus Finch, PharmD, BCSCP Clinical Compounding Pharmacy BPS Certified Sterile Compounding; BCPPS 16 Years Drug compatibility, USP <797>/<800>, CSTD, filters

Evidence Base & Literature Citations

  1. World Association of Medical Editors (WAME). Recommendations on Publication Ethics Policies for Medical Journals. WAME Guidelines; 2022.

Clinical Practice Boundary Notice

This protocol provides evidence-based guidance reflecting INS 2024 Standards of Practice and CDC recommendations. Clinical judgment, institutional policy, and patient-specific variables must guide individualized bedside care.